Device Trial Radar · NCT05750901
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
Last checked: Nov 20, 2026Latest source record: Apr 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
Nov 1, 2022
Primary completion
Dec 20, 2027
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- ScitonNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 2, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Evaluate the safety and efficacy of the fractional ablative laser for treatment of skin laxity and tightening
Conditions
- Skin Laxity
Interventions
Fractional ablative laserDevice
Fractional ablative laser used for treatment for skin laxity and tightening
Primary outcomes
What the sponsor says the trial is designed to measure.
- WrinklesTime frame: 1-6 months post final treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sanctuary Plastic Surgery
Boca Raton, Florida · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.